ArticlePloS one2024

Is tamoxifen good enough for the Asian population in ER+ HER2- post-menopausal women with early breast cancer? A nationwide population-based cohort study.

Chuan-Hsun Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.